TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T84486	Oxytocin receptor	B1OY2B	Vasopressin antagonist 1867	Investigative	11677610	C28H36N4O4	492.6	CC(C)NC(=O)CN1C(=NC2=C(C1=O)C=C(C=C2)OCCCN3CCCCC3)C4=CC(=CC=C4)OC	IC50 ~ 100000 nM	Poor binder
T84486	Oxytocin receptor	B2VKT8	(4S,7R,10S,13R,16R,19S)-16-(2-Amino-2-oxoethyl)-13-(3-amino-3-oxopropyl)-19-((R)-1-((R)-2-(2-aminoacetamido)-4-methylpentanoyl)pyrrolidine-2-carboxamido)-10-sec-butyl-7-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxylic acid	Investigative	53319199	C43H65N11O13S2	1008.2	CC[C@@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N1)CCC(=O)N)CC(=O)N)NC(=O)[C@H]2CCCN2C(=O)[C@@H](CC(C)C)NC(=O)CN)C(=O)O)CC3=CC=C(C=C3)O	Ki ~ 100000 nM	Poor binder
T84486	Oxytocin receptor	B54IQX	Cyclo(CYIQNCPLG)	Investigative	53321821	C42H61N11O12S2	976.1	CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC3=CC=C(C=C3)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]4CCCN4C2=O)CC(C)C)C(=O)N)CCC(=O)N	EC50 ~ 100000 nM	Poor binder
T84486	Oxytocin receptor	BF3AU2	Cyclo(CYIQNCPLGAGAGAG	Investigative	53321822	C58H87N17O18S2	1374.5	CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC3=CC=C(C=C3)O)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]4CCCN4C2=O)CC(C)C)C)C)C)CC(=O)N)CCC(=O)N	Ki ~ 100000 nM	Poor binder
T84486	Oxytocin receptor	BFQ32P	2-(2-(3-Chlorophenyl)-4-oxo-6-(3-(piperidin-1-yl)propoxy)quinazolin-3(4H)-yl)-N-isopropylacetamide	Investigative	11854507	C27H33ClN4O3	497	CC(C)NC(=O)CN1C(=NC2=C(C1=O)C=C(C=C2)OCCCN3CCCCC3)C4=CC(=CC=C4)Cl	IC50 ~ 100000 nM	Poor binder
T84486	Oxytocin receptor	BG9ET3	[Gly(But)3, Gly(But)7]OT	Investigative	44429266	C44H70N12O12S2	1023.2	CC(C)C[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H](C(C)(C)C)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)C(C)(C)C)CC2=CC=C(C=C2)O)N	IC50 = 51700 nM	Poor binder
T84486	Oxytocin receptor	BJTO01	CID 44247566	Investigative	44247566	C25H32ClN5O3	486	CC(C)NC(=O)CN1C(=CN2C(=CC(=N2)OCCCN3CCCCC3)C1=O)C4=CC(=CC=C4)Cl	IC50 ~ 50118.72 nM	Poor binder
T84486	Oxytocin receptor	BK56YW	CID 44467347	Investigative	44467347	C26H33ClN4O3	485	CC(C)NC(=O)CN1C(=CN2C=C(C=C2C1=O)OCCCN3CCCCC3)C4=CC(=CC=C4)Cl	IC50 ~ 50118.72 nM	Poor binder
T84486	Oxytocin receptor	BLI4R6	N-(Cyclopropylmethyl)-2-[6-(3-morpholin-4-ylpropoxy)-4-oxo-2-phenylquinazolin-3-yl]acetamide	Investigative	46934434	C27H32N4O4	476.6	C1CC1CNC(=O)CN2C(=NC3=C(C2=O)C=C(C=C3)OCCCN4CCOCC4)C5=CC=CC=C5	IC50 ~ 100000 nM	Poor binder
T84486	Oxytocin receptor	BN9UL5	(2R)-1-[(4S,7R,10R,13R,16R,19S)-19-Amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2R)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1R)-1-[(2-amino-2-oxoethyl)amino]-3-methylbutyl]pyrrolidine-2-carboxamide	Investigative	53321697	C42H66N12O11S2	979.2	CC[C@@H](C)[C@@H]1C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CSSC[C@H](C(=O)N[C@@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@@H]3C(=O)N[C@H](CC(C)C)NCC(=O)N)CC(=O)N)CCC(=O)N	EC50 ~ 100000 nM	Poor binder
T84486	Oxytocin receptor	BU2FQ9	N-Cyclopentyl-4-methoxy-N-[[2-[4-[[(4-methoxyphenyl)methylamino]methyl]phenyl]-1,3-thiazol-4-yl]methyl]benzenesulfonamide	Investigative	53324622	C31H35N3O4S2	577.8	COC1=CC=C(C=C1)CNCC2=CC=C(C=C2)C3=NC(=CS3)CN(C4CCCC4)S(=O)(=O)C5=CC=C(C=C5)OC	Ki = 50118.72 nM	Poor binder
T84486	Oxytocin receptor	BV6FE1	Lanthionine Oxytocin	Investigative	73346892	C43H65N11O13S	976.1	CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)CC(=O)N)CCC(=O)N	EC50 ~ 100000 nM	Poor binder